In a pancreatic cancer model study by Zheng et al., SNAI1- or TWIST-induced EMT was not found to be essential for the invasion and metastasis of pancreatic cancer, but they suggested that potentially targeting EMT may enhance the efficacy of chemotherapy and immunotherapy [20]. The gene discussed is TWIST1; the disease is pancreatic neoplasm.